Home / Inspections / 1020411

1020411

Crestview Pharma, LLC — FEI 3011825236

Inspection Details

Classification: No Action Indicated (NAI) (NAI)
End Date: July 13, 2017
Fiscal Year: 2017
Product Type: Biologics
Project Area: Human Cellular, Tissue, and Gene Therapies
Location: Aiken, SC (United States)